Altamira Therapeutics Ltd. (CYTOF)
OTCMKTS · Delayed Price · Currency is USD
0.0700
+0.0070 (11.11%)
At close: Aug 14, 2026
Altamira Therapeutics Market Cap
Altamira Therapeutics has a market cap or net worth of $400.08 thousand as of August 14, 2026.
Market Cap
400.08K
Enterprise Value
1.19M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.07
ChartMarket Cap Chart
Since August 8, 2014, Altamira Therapeutics's market cap has decreased from 171.70M to 400.08K, a decrease of -99.77%. That is a compound annual growth rate of -39.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 400.08K | -24.32% |
| Dec 31, 2025 | 528.62K | 40.64% |
| Dec 31, 2024 | 375.87K | -72.84% |
| Dec 29, 2023 | 1.38M | -75.59% |
| Dec 30, 2022 | 5.67M | -78.93% |
| Dec 31, 2021 | 26.91M | -10.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Burzynski Research Institute | 591.52K |
| Halberd | 523.11K |
| THC Farmaceuticals | 505.87K |
| Lyra Therapeutics | 443.72K |
| inTerra Resources | 443.23K |
| Actavia Life Sciences | 385.91K |
| Regen BioPharma | 313.06K |
| Sorrento Therapeutics | 271.86K |